Unfortunately I think he is correct regarding HerVaxx and the B Cell line.... Also, definitely not confident with what's happening with CF33 and the lack of data so far.... The Azel Cell acquisition in the middle of the CF33 trial should be questioned.... Time will tell but it's all hot wind and ongoing innuendo from management
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-203
-
- There are more pages in this discussion • 102 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.1¢ | $717.6K | 13.61M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1468251 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 457393 | 5 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |